No. Both medicines belong to the NSAID class and using them together increases the risk of gastrointestinal bleeding, kidney injury, and cardiovascular events. Discuss alternative pain-relief strategies with your prescriber.
Celebrex has a lower incidence of ulcer formation compared with non-selective NSAIDs because it spares COX-1. However, it can still cause gastrointestinal irritation and, rarely, ulceration, especially in patients with a prior history of ulcer disease.
Celecoxib is not listed as a prohibited substance by the World Anti-Doping Agency (WADA). Routine drug-testing panels for sports generally do not screen for celecoxib, but athletes should disclose any medication use to their medical team.
In the UK, a 100 mg tablet is typically imprinted with “C100” and a 200 mg tablet with “C200”. The exact appearance may vary by manufacturer.
Celebrex is contraindicated in the third trimester of pregnancy because it may cause premature closure of the fetal ductus arteriosus. It should be avoided throughout pregnancy unless the benefits outweigh the risks and a specialist advises otherwise.
Many patients notice a reduction in pain within one hour of taking the first dose, with the peak effect occurring around 2-3 hours.
Elderly individuals can use Celebrex, but they have an increased susceptibility to cardiovascular, renal, and gastrointestinal complications. Dose adjustments and closer monitoring are often recommended.
Take the missed tablet as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing interval. Do not double the dose.
Moderate alcohol consumption does not usually cause a serious interaction, but both alcohol and celecoxib can irritate the stomach lining. Excessive drinking raises the risk of gastrointestinal bleeding and should be avoided.
Yes. Celecoxib is available as a generic prescription medication in the same 100 mg and 200 mg strengths, often at a lower cost than the branded Celebrex.
Celebrex is a brand-name prescription medication that contains the active ingredient celecoxib. It belongs to the pain-relief class of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs), specifically a selective cyclo-oxygenase-2 (COX-2) inhibitor. Celebrex is supplied as a pill in two strengths: 100 mg and 200 mg. In the United Kingdom it is classified as a prescription-only medicine and is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Celecoxib works by selectively inhibiting the COX-2 enzyme. COX-2 is an enzyme that becomes active at sites of inflammation and produces prostaglandins-chemicals that cause pain, swelling, and fever. By blocking COX-2 while sparing the COX-1 enzyme (which protects the stomach lining and supports platelet function), celecoxib reduces pain and inflammation with a lower risk of stomach irritation compared with traditional NSAIDs.
Celecoxib is absorbed from the gastrointestinal tract, reaches peak plasma concentrations in about 3 hours, and is metabolised primarily by the liver enzyme CYP2C9. About 97 % of the dose is eliminated in the urine, either unchanged or as metabolites.
Celebrex is approved by the MHRA for the following indications:
These indications are based on clinical trials that demonstrated celecoxib’s efficacy in reducing pain scores and improving functional outcomes compared with placebo or other NSAIDs.
Evidence from peer-reviewed studies suggests that celecoxib has been explored for a limited number of off-label uses, such as:
These uses are not approved by the MHRA or the European Medicines Agency (EMA). Off-label use requires supervision by a qualified healthcare professional, and the potential benefits must be weighed against known cardiovascular and gastrointestinal risks.
These effects are usually mild and transient. If they persist, patients should discuss management with a healthcare professional.
Standard dosing (based on the 100 mg and 200 mg tablets):
Osteoarthritis, rheumatoid arthritis, ankylosing spondylitis:
200 mg once daily, or 100 mg twice daily.
Acute pain:
200 mg twice daily (total 400 mg per day) for the first 1-2 days, then 200 mg once daily as needed.
Primary dysmenorrhea:
200 mg once daily for up to 3 days, starting at the onset of menstrual pain.
Administration: Swallow the pill whole with water. Do not crush, chew, or split the tablet unless a specific formulation (e.g., dispersible) is prescribed.
Missed dose: Take the missed tablet as soon as remembered unless it is near the time of the next scheduled dose; do not double-dose.
Overdose: Symptoms may include nausea, vomiting, abdominal pain, and drowsiness. Seek emergency medical care; activated charcoal may be considered if presentation is early.
Discontinuation: Celecoxib does not usually require tapering. However, patients with long-term use should discuss a gradual cessation with a healthcare provider to monitor for rebound pain or inflammation.
All dosing decisions must be individualized by a prescriber based on the patient’s condition, response, and comorbidities.
This article provides educational information about Celebrex and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
